Use of hydroxyethyl starch in sepsis research: A systematic review with meta-analysis

被引:3
|
作者
Johansen, Jes R. [1 ]
Perner, Anders [1 ]
Brodtkorb, Julie H. [1 ]
Moller, Morten H. [1 ]
机构
[1] Univ Copenhagen, Rigshosp, Dept Intens Care, Copenhagen, Denmark
关键词
adverse effects; hydroxyethyl starch (HES) 130/0.38-0.45; sepsis; RESUSCITATION; 6-PERCENT; MANAGEMENT; OUTCOMES; SALINE;
D O I
10.1111/aas.13954
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: After being used for more than a decade the use of hydroxyethyl starch (HES) 130/0.38-0.45 in clinical practice was discouraged because of serious adverse events including bleeding, acute kidney injury and death. But could these adverse effects have been discovered sooner? By comparing the summary effect estimates of the adverse effects of HES 130/0.38-0.45 in different study designs we aimed to disclose any signal of this. Methods: We systematically searched MEDLINE, EMBASE and Cochrane Library and hand-searched the reference lists of relevant studies to identify studies for inclusion. Eligible trials were randomised clinical trials (RCTs) and observational studies in patients with sepsis and randomised trials in animals with induced sepsis comparing HES 130/0.38-0.45 to any type of crystalloid. Relevant outcomes were all-cause mortality at longest follow-up, renal replacement therapy (RRT), acute kidney injury (AKI) and bleeding. We extracted data, conducted conventional meta-analyses and assessed the risk of bias and the quality of evidence. Results: We included 8 RCTs including 3,273 patients, 1 observational study including 379 patients and 5 randomised animal trials including 94 test animals. There was no suggestion of interaction in subgroup analyses comparing the different study designs for any outcomes (all-cause mortality at longest follow-up p = .33; RRT p = .70; AKI p = .63; bleeding p = .20). Conclusions: We observed no interaction between the summary effect estimates of RCTs, observational studies in patients and randomised animal trials for any of the outcomes. Accordingly, we found no evidence indicating that the adverse effects of HES 130/0.38-0.45 could have been discovered sooner. Systematic review registration: PROSPERO ID: CRD42018103422. Protocol Johansen JR, Perner A, Brodtkorb JH, Moller MH. Use of hydroxyethyl starch in sepsis research: Protocol for a systematic review. Acta Anaesthesiol Scand. 2019;63:814-818.
引用
收藏
页码:1355 / 1364
页数:10
相关论文
共 50 条
  • [1] Use of hydroxyethyl starch in sepsis research: Protocol for a systematic review
    Johansen, Jes R.
    Perner, Anders
    Brodtkorb, Julie H.
    Moller, Morten H.
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2019, 63 (06) : 814 - 818
  • [2] Comparison of hydroxyethyl starch colloids with crystalloids for surgical patients A systematic review and meta-analysis
    Raiman, Mohamed
    Mitchell, Colin G.
    Biccard, Bruce M.
    Rodseth, Reitze N.
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2016, 33 (01) : 42 - 48
  • [3] Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis
    Haase, Nicolai
    Perner, Anders
    Inkeri, Louise
    Siegemund, Martin
    Lauridsen, Bo
    Wetterslev, Mik
    Wetterslev, Jorn
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [4] Randomised trials of 6 % tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis
    Patel, Amit
    Waheed, Umeer
    Brett, Stephen J.
    INTENSIVE CARE MEDICINE, 2013, 39 (05) : 811 - 822
  • [5] Randomised trials of 6 % tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis
    Amit Patel
    Umeer Waheed
    Stephen J. Brett
    Intensive Care Medicine, 2013, 39 : 811 - 822
  • [6] The Use Of Procalcitonin Test In Patients With Sepsis: A Systematic Review And Meta-Analysis
    Lee, H.
    Cho, S.
    Suh, J.
    Jang, B.
    Lee, S. -M.
    Kim, J.
    Hong, S. -B.
    Na, S.
    Ryu, H.
    Jeon, K.
    Ko, M.
    Jang, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [7] Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis
    Wiedermann C.J.
    BMC Emergency Medicine, 8 (1)
  • [8] Use of melatonin as adjunctive therapy in neonatal sepsis: A systematic review and meta-analysis
    Henderson, Renesha
    Kim, Seungyeon
    Lee, Euni
    COMPLEMENTARY THERAPIES IN MEDICINE, 2018, 39 : 131 - 136
  • [9] Corticosteroids in Sepsis: An Updated Systematic Review and Meta-Analysis
    Rochwerg, Bram
    Oczkowski, Simon J.
    Siemieniuk, Reed A. C.
    Agoritsas, Thomas
    Belley-Cote, Emilie
    D'Aragon, Frederick
    Duan, Erick
    English, Shane
    Gossack-Keenan, Kira
    Alghuroba, Mashari
    Szczeklik, Wojciech
    Menon, Kusum
    Alhazzani, Waleed
    Sevransky, Jonathan
    Vandvik, Per Olav
    Annane, Djillali
    Guyatt, Gordon
    CRITICAL CARE MEDICINE, 2018, 46 (09) : 1411 - 1420
  • [10] RESTRICTIVE FLUIDS IN SEPSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Stefanos, Sylvia S.
    Reynolds, Paul
    MacLaren, Robert
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 32 - 32